56.88
Schlusskurs vom Vortag:
$56.05
Offen:
$56.37
24-Stunden-Volumen:
1.71M
Relative Volume:
0.84
Marktkapitalisierung:
$27.70B
Einnahmen:
$25.68B
Nettoeinkommen (Verlust:
$527.00M
KGV:
53.16
EPS:
1.07
Netto-Cashflow:
$839.00M
1W Leistung:
-1.85%
1M Leistung:
-6.74%
6M Leistung:
+12.19%
1J Leistung:
+22.32%
Nutrien Ltd Stock (NTR) Company Profile
Firmenname
Nutrien Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie NTR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NTR
Nutrien Ltd
|
56.88 | 27.23B | 25.68B | 527.00M | 839.00M | 1.07 |
![]()
CTVA
Corteva Inc
|
72.33 | 48.24B | 17.18B | 1.48B | 2.59B | 2.05 |
![]()
CF
Cf Industries Holdings Inc
|
86.42 | 13.43B | 6.13B | 1.34B | 1.86B | 7.59 |
![]()
MOS
Mosaic Company
|
32.21 | 9.90B | 11.06B | 367.80M | 212.50M | 1.16 |
![]()
ICL
Icl Group Ltd
|
6.09 | 7.65B | 6.84B | 407.00M | 755.00M | 0.32 |
Nutrien Ltd Stock (NTR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-11 | Herabstufung | Jefferies | Buy → Hold |
2025-06-17 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2025-05-14 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
2025-03-13 | Eingeleitet | Goldman | Sell |
2025-01-21 | Herabstufung | Barclays | Overweight → Equal Weight |
2025-01-13 | Hochstufung | JP Morgan | Underweight → Neutral |
2025-01-13 | Hochstufung | Piper Sandler | Underweight → Overweight |
2024-12-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2024-10-10 | Herabstufung | UBS | Buy → Neutral |
2024-09-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2024-09-10 | Herabstufung | Goldman | Buy → Neutral |
2024-08-02 | Herabstufung | HSBC Securities | Hold → Reduce |
2024-04-29 | Hochstufung | Berenberg | Hold → Buy |
2024-03-26 | Eingeleitet | Jefferies | Buy |
2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
2024-02-29 | Herabstufung | Piper Sandler | Neutral → Underweight |
2024-02-23 | Herabstufung | JP Morgan | Neutral → Underweight |
2024-01-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2023-11-30 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
2023-11-14 | Hochstufung | Barclays | Underweight → Overweight |
2023-11-06 | Herabstufung | JP Morgan | Overweight → Neutral |
2023-08-14 | Herabstufung | Barclays | Overweight → Underweight |
2023-07-31 | Hochstufung | TD Securities | Hold → Buy |
2023-07-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2023-05-17 | Herabstufung | Berenberg | Buy → Hold |
2023-05-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2023-04-10 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
2023-02-08 | Herabstufung | TD Securities | Buy → Hold |
2023-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2023-01-19 | Eingeleitet | Wells Fargo | Equal Weight |
2023-01-09 | Fortgesetzt | Credit Suisse | Underperform |
2022-11-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
2022-11-03 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
2022-10-21 | Herabstufung | HSBC Securities | Buy → Hold |
2022-08-09 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
2022-07-14 | Eingeleitet | Credit Suisse | Underperform |
2022-06-01 | Eingeleitet | Barclays | Overweight |
2022-03-28 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
2022-03-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
2022-02-18 | Hochstufung | Atlantic Equities | Underweight → Neutral |
2021-12-17 | Eingeleitet | Piper Sandler | Neutral |
2021-10-13 | Eingeleitet | Mizuho | Neutral |
2021-09-14 | Bestätigt | BofA Securities | Buy |
2021-06-29 | Hochstufung | Susquehanna | Neutral → Positive |
2021-06-15 | Herabstufung | Raymond James | Strong Buy → Outperform |
2021-05-24 | Hochstufung | HSBC Securities | Hold → Buy |
2021-02-23 | Herabstufung | HSBC Securities | Buy → Hold |
2021-01-12 | Herabstufung | Atlantic Equities | Neutral → Underweight |
2020-12-03 | Herabstufung | Susquehanna | Positive → Neutral |
2020-08-25 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
2020-05-14 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
2020-05-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
2020-04-09 | Hochstufung | Citigroup | Neutral → Buy |
2020-03-26 | Hochstufung | Goldman | Neutral → Buy |
2020-03-02 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2020-03-02 | Hochstufung | JP Morgan | Neutral → Overweight |
2020-02-27 | Hochstufung | Berenberg | Hold → Buy |
2020-02-14 | Herabstufung | Citigroup | Buy → Neutral |
2020-02-10 | Herabstufung | Cleveland Research | Buy → Neutral |
2020-01-23 | Herabstufung | Stephens | Overweight → Equal-Weight |
2020-01-15 | Herabstufung | Bernstein | Outperform → Mkt Perform |
2019-11-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
2019-09-23 | Eingeleitet | Consumer Edge Research | Overweight |
2019-08-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
2019-04-23 | Bestätigt | Cowen | Outperform |
2019-03-06 | Bestätigt | Cowen | Outperform |
2018-12-13 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Nutrien Ltd Aktie (NTR) Neueste Nachrichten
Nutrien’s SWOT analysis: ag giant’s stock faces mixed market conditions By Investing.com - Investing.com Australia
Nutrien (NTR): Navigating Fertilizer Market Recovery Amid Analyst Price Target Hikes - AInvest
Wells Fargo Edges Up Nutrien (NYSE:NTR) Price Target, Keeps Cautious Stance Amid Fertilizer Market Recovery - Insider Monkey
What is Nutrien Ltd. s debt to equity ratio2025 Earnings Impact & Reliable Entry Point Alerts - newsyoung.net
Nutrien's Q2 Earnings Beat Estimates on Record Potash Volumes - Nasdaq
Nutrien Ltd. (NTR) Stock Forecasts - Yahoo Finance
Community grants support summer in the city of Saskatoon - Nutrien
Meet Robert Dickson: Brightening Farmers’ Days for over 50 years - Nutrien
Is Nutrien Ltd. stock risky to hold nowEarnings Surprise Driven Picks - 뉴스임팩트
Earnings Surge and Potash Guidance Boost Could Be a Game Changer for Nutrien (TSX:NTR) - simplywall.st
Nutrien Shares Rise After Upgrade From JPMorgan - MarketScreener
NTR: Scotiabank Lowers Price Target, Maintains Sector Perform Ra - GuruFocus
Nutrien: TD Securities raises Buy rating, PT to $72 from $70. - AInvest
J.P. Morgan Upgrades Nutrien to Buy with $68 Price Target - AInvest
Nutrien Ltd.’s Price Action Aligns with Quant SignalsGrowth Focused Entry Plan Suggestions Issued - beatles.ru
Nutrien Reports Strong Q2 2025 Earnings Amid Favorable Market - TipRanks
JPMorgan upgrades Nutrien stock to Overweight on favorable fertilizer market outlook - Investing.com
Is Nutrien Ltd. exposed to political riskFree Swing Trade Tracker - classian.co.kr
TD Securities Lifts Nutrien (NTR) PT to C$70, Raises Potash Sales Forecast - Insider Monkey
What indicators show strength in Nutrien Ltd.Buy Entry Confirmation Based on Technical Analysis - Newser
Regression analysis insights on Nutrien Ltd. performanceFree Trend Following Strategy With Stop Loss - Newser
Nutrien's Record Earnings Clashes with 473rd Volume Rank as Shares Drop 6.9% - AInvest
Nutrien Ltd. (NYSE:NTR) Q2 2025 Earnings Call Transcript - MSN
Nutrien stock rises after beating profit forecasts on record potash sales - MSN
Nutrien Earnings: Shares Fall on Higher Unit Costs and Potash Price Concerns; We Disagree - Morningstar
Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Jefferies lowers Nutrien stock price target to $61 on mixed outlook - Investing.com Australia
Nutrien Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Nutrien says tight nitrogen supply will drive demand, despite affordability crunch - Quantum Commodity Intelligence
Nutrien Reports Strong Q2 2025 Results Amid Fertilizer Market Demand - The Globe and Mail
Nutrien's Low-Cost Potash and Nitrogen Should Generate Solid Profits at Midcycle Prices - Morningstar
Nutrien Ltd. shares fall 3.33% intraday after UBS maintains Neutral rating and revises target price. - AInvest
Earnings call transcript: Nutrien Q2 2025 shows EPS beat, revenue miss - Investing.com
Nutrien expects more fertilizer use by farmers despite low crop prices - Yahoo Finance
Nutrien Ltd. (NTR): A Case Study in Fertilizer Market Mastery Amid 2025's Supply-Demand Imbalance - AInvest
Nutrien bullish on North American nitrogen demand - Quantum Commodity Intelligence
Nutrien Ltd.'s 2025 Q2 Earnings and Strategic Position in a Shifting Agronomy Landscape - AInvest
Learn to Evaluate (NTR) using the Charts (NTR:CA) - news.stocktradersdaily.com
Nutrien Q2 2025 slides: Potash and nitrogen drive growth amid tight global supply - Investing.com Nigeria
Nutrien Ltd. Q2 Earnings Exceed Expectations but Revenue Falls ShortNews and Statistics - IndexBox
Nutrien Reports Q2 2025 Results, Increases Potash Guidance Amid Higher Fertilizer Demand - iGrow News
Nutrien: Q2 Earnings Snapshot - The Washington Post
Nutrien Ltd. Q2 Profit Increases, Beats Estimates - Nasdaq
Compared to Estimates, Nutrien (NTR) Q2 Earnings: A Look at Key Metrics - sharewise.com
Nutrien (NTR) Surpasses Earnings Forecasts on Strong Fertilizer Demand - GuruFocus
Nutrien Declares Quarterly Dividend of US$0.545 per Share - TipRanks
Nutrien Reports Strong Q2 2025 Results Amid Favorable Fertilizer Market - TipRanks
Finanzdaten der Nutrien Ltd-Aktie (NTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):